Clinical Trials on Amphetamine-Related Disorders in United States

Total 67166 results

University of Texas Southwestern Medical Center
Stanley Medical Research Institute

Completed

A Pilot Study of Citicoline add-on Therapy in Patients With Bipolar Disorder or Major Depressive Disorder and Amphetamine Abuse or Dependence

Bipolar Disorder | Major Depressive Disorder | Amphetamine Dependence | Amphetamine Abuse

United States
University of Virginia
American Association of Chairs of Departments of Psychiatry

Withdrawn

Dose Response of Mirtazapine to Methamphetamine Induced Interest, Mood Elevation and Reward

Amphetamine Dependence

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Long-term Behavior Change - 1

Amphetamine-related Disorders

United States
California Pacific Medical Center Research Institute

Unknown

A Dose Ranging Study of Modafinil for Methamphetamine Dependence

Substance Dependence | Amphetamine Dependence

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Study of Medical Treatment for Methamphetamine Addiction (BUP PGx)

Substance Abuse | Methamphetamine | Pharmacogenetics | Methamphetamine Dependence | Amphetamine Dependence

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

An Assessment of the Safety of Varenicline in Methamphetamine-dependent Volunteers

Methamphetamine Addiction | Crystal Meth Addiction | Amphetamine Addiction

United States
University of Southern California
National Institute on Drug Abuse (NIDA); University of Toronto; RTI International

Completed

Change the Cycle: An RCT to Prevent Injection Initiation (CTC)

Substance Abuse, Intravenous | HIV | Heroin Dependence | Opioid Dependence | Cocaine Dependence | Amphetamine Dependence

United States
National Institute on Drug Abuse (NIDA)

Unknown

A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

Effects of Stimulant Dependence on Human Striatal Dopamine System - 15

Tobacco Use Disorder | Amphetamine-Related Disorders

United States
Portland VA Research Foundation, Inc
Steven & Alexandra Cohen Foundation

Recruiting

Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Tyrosine for Methamphetamine Dependence - 1

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

To Assess the Safety and Tolerability of 7.5, 15 and 30 mg of Sublingual Lobeline. - 1

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

Assessment of Interactions Between Intravenous Methamphetamine and Modafinil - 1

Amphetamine-Related Disorders

United States
Laureate Institute for Brain Research, Inc.

Recruiting

Floatation-REST in Methamphetamine Use Disorder: A Pilot Study

Amphetamine-Type Substance Use Disorder

United States
California Pacific Medical Center Research Institute

Unknown

A Cognitive Behavioral Therapy-Based Text Message Intervention for Methamphetamine Dependence

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

Assessment of Interactions Between Methamphetamine and Aripiprazole - 1

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of California, Los Angeles

Unknown

Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

Cognitive Correlates of Substance Abuse, Part 2 - 16

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

Cognitive Correlates of Substance Abuse - 11

Amphetamine-Related Disorders

United States
Phillip Coffin, MD, MIA
National Institute on Drug Abuse (NIDA)

Completed

Mirtazapine for the Treatment of Methamphetamine Dependence Among MSM (M2.0)

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Bupropion for the Treatment of Methamphetamine Dependence - 1

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Texas

Completed

Ondansetron for the Treatment of Methamphetamine Dependence - 1

Amphetamine-Related Disorders

United States
San Francisco Department of Public Health
National Institute on Drug Abuse (NIDA); Alkermes, Inc.

Completed

Extended-Release Naltrexone to Treat Methamphetamine Dependence in Men Who Have Sex With Men (MSM) (TREX)

Amphetamine-Related Disorders

United States
Laureate Institute for Brain Research, Inc.
Oklahoma Center for the Advancement of Science and Technology

Completed

Neurocognitive Empowerment for Addiction Treatment (NEAT) in Opioid Use Disorder and Amphetamine Use Disorder (NEAT)

Opioid-use Disorder | Amphetamine Use Disorders

United States
Laureate Institute for Brain Research, Inc.

Completed

Transcranial Direct Current Stimulation to Modulate Top-Down Regulation for Drug Craving in Methamphetamine Use Disorder (NeuroMethDC)

Amphetamine Use Disorders

United States
Friends Research Institute, Inc.
University of California, Los Angeles

Completed

Contingency Management for Methamphetamine Abstinence and HIV Post-Exposure Prophylaxis in Men Who Have Sex With Men

HIV Infections | HIV | Amphetamine-Related Disorders

United States
University of California, San Francisco

Completed

Oxytocin HIV Meth Study (OHM)

Amphetamine Use Disorders

United States
New River Pharmaceuticals

Completed

Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant Abuse

Substance-Related Disorders | Attention Deficit Disorder With Hyperactivity | Amphetamine-Related Disorders

United States
New River Pharmaceuticals

Completed

Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories

Substance-Related Disorders | Attention Deficit Disorder With Hyperactivity | Amphetamine-Related Disorders

United States
London School of Hygiene and Tropical Medicine

Completed

Conflict Between Maternal Autonomy and Child Health in Substance-use

Substance-Related Disorders | Substance Abuse, Intravenous | Alcohol-Related Disorders | Pregnancy | Marijuana Abuse | Opioid-Related Disorders | Cocaine-Related Disorders | Neonatal Abstinence Syndrome | Amphetamine-Related Disorders | Inhalant Abuse | Pregnancy, High-Risk

United Kingdom
Leslie Swanson
National Institute of Mental Health (NIMH); University of Michigan; Natrol

Not yet recruiting

Correcting Circadian Rhythms to Breakthrough in Bipolar Disorder

Bipolar Disorder | Delayed Sleep-Wake Phase Disorder

United States
Cambridge Health Alliance
National Center for Complementary and Integrative Health (NCCIH)

Completed

MINDFUL-OBOT: Effect of Mindfulness on Opioid Use and Anxiety During Primary Care Buprenorphine Treatment

Depression | Anxiety | Opioid-use Disorder | Stress Related Disorder

United States
University of Pittsburgh
National Institute on Drug Abuse (NIDA)

Enrolling by invitation

STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy (STEPuP)

Pregnancy Related | Opioid-use Disorder

United States
Kyle Kampman
National Institute on Drug Abuse (NIDA)

Recruiting

Cariprazine for Comorbid Cocaine and Opioid Use Disorder

Opioid-use Disorder | Cocaine Use Disorder

United States
Cambridge Health Alliance
National Center for Complementary and Integrative Health (NCCIH)

Completed

Effect of Mindfulness on Opioid Use and Anxiety During Primary Care Buprenorphine Treatment (R33 Phase) (Mindful-OBOT)

Depression | Anxiety | Opioid-use Disorder | Stress Related Disorder

United States
University of Utah

Completed

Perinatal Care and Medication Assisted Treatment: Carbon/Emery Counties

Pregnancy Related | Opioid-use Disorder

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA); RTI International; University of Maryland...

Completed

Navigation Services to Avoid Rehospitalization (NavSTAR) (NavSTAR)

Alcohol Use Disorder | Opioid-use Disorder | Cocaine Use Disorder

United States
William Stoops
National Institute on Drug Abuse (NIDA)

Recruiting

Behavioral Effects of Drugs (Inpatient): 43 (Opioids, Cocaine, n-Acetylcysteine) (BED IN 43)

Opioid Use Disorder | Cocaine Use Disorder

United States
Johns Hopkins University

Recruiting

Suvorexant for Opioid/Stimulant Co-use

Opioid Use Disorder | Stimulant Use Disorder

United States
Friends Research Institute, Inc.

Recruiting

Extended Release Naltrexone Versus Extended Release Buprenorphine With Individuals Leaving Jail

Opioid-use Disorder

United States
Allegheny Singer Research Institute (also known...
Abbott

Recruiting

Deep Brain Stimulation Effects In Patients With Opioid Use Disorder

Opioid-use Disorder

United States
National Institute on Drug Abuse (NIDA)

Recruiting

Biased Opioid Agonists for Treatment of Opioid Withdrawal in OUD

Opioid-Use Disorder

United States
Mclean Hospital

Completed

Stress Response in Opioid Use Disorder

Opioid-use Disorder

United States
Denver Health and Hospital Authority
Centers for Disease Control and Prevention

Completed

Connection, Navigation, Engagement in Care and Treatment for Opioid Use Disorder (ConNECT)

Opioid-use Disorder

United States
Go Medical Industries Pty Ltd
National Institute on Drug Abuse (NIDA); Columbia University; New York State... and other collaborators

Completed

Pharmacokinetic Study of Vivitrol in Healthy Participants

Opioid-use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Suspended

Extended-Release Buprenorphine vs. Sublingual Buprenorphine for the Treatment of Opioid Use Disorder

Opioid-use Disorder

United States
University of Delaware
Harvard Medical School (HMS and HSDM); National Institute on Drug Abuse (NIDA) and other collaborators

Completed

Disclosure Intervention for People in Recovery From Opioid Use Disorder

Opioid-use Disorder

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Active, not recruiting

Subthreshold Opioid Use Disorder Prevention (STOP) Trial

Opioid-use Disorder

United States
University of Minnesota

Active, not recruiting

Contingency Management for Opioid and Stimulant Use Disorders in Primary Care

Opioid Use Disorder | Stimulant Use Disorder

United States

Clinical Trials on Amphetamine-Related Disorders in United States

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations